| Literature DB >> 18596975 |
Patrícia Abrantes1, George Dimopoulos, Ana Rita Grosso, Virgílio E do Rosário, Henrique Silveira.
Abstract
BACKGROUND: Plasmodium development in the mosquito is crucial for malaria transmission and depends on the parasite's interaction with a variety of cell types and specific mosquito factors that have both positive and negative effects on infection. Whereas the defensive response of the mosquito contributes to a decrease in parasite numbers during these stages, some components of the blood meal are known to favor infection, potentiating the risk of increased transmission. The presence of the antimalarial drug chloroquine in the mosquito's blood meal has been associated with an increase in Plasmodium infectivity for the mosquito, which is possibly caused by chloroquine interfering with the capacity of the mosquito to defend against the infection. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2008 PMID: 18596975 PMCID: PMC2432468 DOI: 10.1371/journal.pone.0002587
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1MA-plots of the normalized data (Log2-ratio plotted against average.
Log Intensity) for each experimental group (Chl 50 and Chl 50Pb) with a Log2 ratio cut-off of 0.58 (i.e., 1.5-fold change). Only those genes that were up- or down-regulated more than 1.5 fold were considered to be differentially expressed.
Figure 2Pie charts indicating the relative proportions of functional gene groups regulated in chloroquine-treated mosquitoes (Chl 50) and P. berghei-infected chloroquine treated (Chl 50Pb) mosquitoes.
The functional groups and their corresponding colors in the pie charts are indicated, as well as the total numbers of genes represented in each pie. Ambiguous groups were excluded from this analysis.
List of genes demonstrating changes in transcript level [fold-increase or decrease (indicated by minus symbol)] in response to the presence of chloroquine in the blood meal of non-infected (Chl 50) and P. berghei-infected (Chl 50Pb) mosquitoes.
| EnsEMBL GeneID | ClusterID | Family Description | Gene Name | Chl50 | Chl50Pb |
|
| |||||
| ENSANGG00000019348 | TCLAG003112 | ACYL COA DEHYDROGENASE CHAIN-SPECIFIC MITOCHONDRIAL PRECURSOR | 1.5698 | ||
| ENSANGG00000017291 | BBB | ALDO KETO REDUCTASE FAMILY 1 MEMBER | 1.5342 | ||
| ENSANGG00000018830 | TCLAG069348 | ADENOSYLHOMOCYSTEINASE | −1.7918 | −1.5698 | |
| ENSANGG00000009921 | TCLAG041742 | CYTOCHROME B5-RELATED | −1.7021 | ||
| ENSANGG00000019581 | TCLAG028881 | CYTOCHROME C OXIDASE POLYPEPTIDE VA MITOCHONDRIAL PRECURSOR | −1.5566 | ||
| ENSANGG00000007821 | TCLAG065534 | CYTOCHROME C OXIDASE POLYPEPTIDE VIA MITOCHONDRIAL PRECURSOR | −1.5242 | ||
| ENSANGG00000001777 | TCLAG062787 | CYTOCHROME P450 | −1.6099 | ||
| ENSANGG00000020954 | TCLAG036258 | CYTOCHROME P450 | −1.5269 | 2.0305 | |
| ENSANGG00000007941 | TCLAG012847 | CYTOCHROME P450 |
| −1.5376 | |
| ENSANGG00000023588 | TCLAG023097 | CYTOCHROME P450 |
| 1.5153 | |
| ENSANGG00000019213 | TCLAG003085 | CYTOCHROME P450 2 | −1.6987 | ||
| ENSANGG00000023782 | TCLAG015411 | CYTOCHROME P450 2 |
| 1.5940 | |
| ENSANGG00000020954 | BBB | CYTOCHROME P450 2 | 2.5172 | ||
| ENSANGG00000014854 | TCLAG067148 | PEROXIDASE PRECURSOR | −1.8468 | ||
| ENSANGG00000014067 | TCLAG022599 | SULFIDE:QUINONE OXIDOREDUCTASE MITOCHONDRIAL PRECURSOR EC 1 | −1.4966 | ||
| ENSANGG00000007829 | TCLAG040227 | NADH UBIQUINONE OXIDOREDUCTASE B16 6 SUBUNIT | 1.5471 | ||
| ENSANGG00000015380 | TCLAG003027 | NADH UBIQUINONE OXIDOREDUCTASE 13 KDA B SUBUNIT | −1.8273 | ||
| ENSANGG00000001732 | TCLAG055584 | NADH UBIQUINONE OXIDOREDUCTASE B8 SUBUNIT | −1.5969 | ||
| ENSANGG00000013573 | TCLAG005781 | NADH UBIQUINONE OXIDOREDUCTASE SGDH SUBUNIT MITOCHONDRIAL PRECURSOR | −1.5362 | ||
| ENSANGG00000009948 | TCLAG063680 | DEHYDROGENASE | −1.5414 | ||
| ENSANGG00000011473 | TCLAG024974 | PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE GPX 4 | −1.5444 | ||
| ENSANGG00000013675 | TCLAG026842 | SUPEROXIDE DISMUTASE [CU ZN] |
| −1.6366 | |
| ENSANGG00000018555 | TCLAG045874 | THIOREDOXIN 1 |
| −1.6651 | |
|
| |||||
| ENSANGG00000019836 | TCLAG046632 | ANGIOTENSIN-CONVERTING ENZYME PRECURSOR | 1.8071 | ||
| ENSANGG00000008128 | BBB | APOLIPOPROTEIN D PRECURSOR | 1.7579 | ||
| ENSANGG00000010933 | TCLAG018194 | SERINE PROTEASE SNAKE PRECURSOR |
| −1.5518 | |
| ENSANGG00000015439 | TCLAG011975 | C-TYPE LECTIN |
| 1.5190 | |
| ENSANGG00000018677 | TCLAG002517 | C-TYPE LECTIN |
| −1.4948 | |
| ENSANGG00000009869 | TCLAG038131 | LEUCINE RICH REPEAT SHOC 2 RAS BINDING SUR 8 | −1.5731 | ||
| ENSANGG00000019730 | TCLAG042327 | LEUCINE RICH REPEATS AND IMMUNOGLOBULIN DOMAINS PRECURSOR | 1.5522 | ||
| ENSANGG00000017763 | TCLAG035574 | AMBIGUOUS |
| 1.5688 | |
| ENSANGG00000010766 | TCLAG044876 | GAMBICIN |
| −1.6314 | |
| ENSANGG00000015950 | TCLAG011952 | LYSOZYME C | 1.8200 | ||
| ENSANGG00000011459 | TCLAG019577 | PEPTIDOGLYCAN RECOGNITION PRECURSOR |
| −1.6232 | −1.6462 |
| ENSANGG00000002044 | TCLAG001576 | PROPHENOLOXIDASE |
| −1.4966 | |
| ENSANGG00000016043 | TCLAG034331 | PROTEASE INHIBITORS PRECURSOR | 2.5373 | ||
| ENSANGG00000013344 | TCLAG002324 | SERPIN fragment SRPN10 |
| −1.8327 | |
| ENSANGG00000015301 | TCLAG065690 | SUPPRESSOR OF CYTOKINE SIGNALING |
| 1.5491 | |
| ENSANGG00000011993 | TCLAG034787 | UNKNOWN |
| −1.6003 | |
|
| |||||
| ENSANGG00000016869 | TCLAG043243 | SPHINGOMYELIN PHOSPHODIESTERASE PRECURSOR | −1.5815 | −1.5318 | |
| ENSANGG00000024926 | TCLAG005775 | BACULOVIRAL IAP REPEAT CONTAINING INHIBITOR OF APOPTOSIS |
| −1.6325 | −1.5409 |
| ENSANGG00000006560 | TCLAG035786 | CASPASE 3 PRECURSOR |
| −1.4986 | |
|
| |||||
| ENSANGG00000017996 | TCLAG004477 | CHITINASE |
| −1.7583 | |
| ENSANGG00000019293 | TCLAG011432 | CUTICLE 6 BCNCP14 10 | −1.5872 | 1.5384 | |
| ENSANGG00000018296 | TCLAG006156 | CATHEPSIN B CYSTEINE PROTEINASE PRECURSOR | −1.7229 | ||
|
| |||||
| ENSANGG00000013908 | TCLAG059498 | ACTIN | −1.7639 | ||
| ENSANGG00000011396 | BBB | ARP2/3 COMPLEX 41 KDA SUBUNIT | −2.3824 | ||
| ENSANGG00000024209 | BBB | PHOSPHATIDYLETHANOLAMINE BINDING PEBP HCNPPP | −1.6014 | ||
| ENSANGG00000011568 | TCLAG031086 | RHO GDP DISSOCIATION INHIBITOR | −1.6444 | ||
| ENSANGG00000008564 | TCLAG039850 | T COMPLEX 1 SUBUNIT |
| −1.5237 | |
| ENSANGG00000015160 | TCLAG020950 | TUBULIN-SPECIFIC CHAPERONE A TUBULIN FOLDING COFACTOR |
| −1.9358 | |
| ENSANGG00000021087 | TCLAG032247 | TUBULIN CHAIN |
| −1.5924 | |
| ENSANGG00000014294 | TCLAG039279 | COLLAGEN ALPHA CHAIN |
| 1.4956 | |
| ENSANGG00000010625 | TCLAG007248 | DNAJ | 1.5818 | ||
| ENSANGG00000015665 | TCLAG020060 | MYOSIN LIGHT CHAIN |
| 2.2895 | |
| ENSANGG00000006332 | TCLAG020425 | TROPOMYOSIN | 1.5502 | ||
|
| |||||
| ENSANGG00000021140 | TCLAG012865 | INNEXIN | 1.6587 | ||
| ENSANGG00000016731 | TCLAG064627 | UNKNOWN |
| 2.5155 | |
Genes are grouped according to the following functional classes: oxidative stress, immunity, apoptosis, extracellular matrix, cytoskeleton and adhesion.